The DOI matches its Crossref record.
Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases
Abstract
Objective: Glutamic acid decarboxylase (GAD) catalyzes the conversion of glutamic acid into GABA. GAD autoantibodies (GAD‐Ab) have been described in diabetes mellitus and in diseases involving the central nervous system such as stiff‐person syndrome and cerebellar ataxia. However, the pathogenic role of GAD‐Ab in neurological diseases remains a matter of debate. Methods: Using neurophysiological and neurochemical methods, we analyzed the effects of intracerebellar and paraspinal administration of GAD‐Ab in rats. Results: Intracerebellar administration of IgG from patients with GAD‐Ab and neurological involvement (IgG‐GAD) blocked the potentiation of the corticomotor response normally associated with trains of repetitive peripheral nerve stimulation. When injected in the lumbar paraspinal region, IgG‐GAD induced continuous motor activity with repetitive discharges, abnormal exteroceptive reflexes, and increased excitability of anterior horn neurons, as assessed by F/M ratios. Furthermore, IgG‐GAD significantly reduced the N‐methyl‐D‐aspartate–mediated production of nitric oxide in cerebellar nuclei and impaired the synaptic regulation of glutamate after N‐methyl‐D‐aspartate administration. These effects were not observed after administration of IgG from the following groups: (1) patients with GAD‐Ab, diabetes mellitus, and without neurological complications; and (2) control patients. Interpretation: These results indicate that stiff‐person syndrome and cerebellar ataxia are the direct consequence of antibody‐mediated neuronal dysfunction. Ann Neurol 2007;61:544–551
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 542
Infections, inflammation and epilepsy
Vezzani, A., Fujinami, R. S., White, H. S., Preux, P.-M., Blümcke, I., Sander, J. W., & Löscher, W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1481-5 · Cited by 518
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Metadata
- Authors
- Manto, M., Laute, M., Aguera, M., Rogemond, V., Pandolfo, M., & Honnorat, J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-06
- Volume
- 61
- Issue
- 6
- Pages
- 544-551
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2159165179
- Cited by
- 249
- References
- 0
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases. https://app.cochat.ai/papers/10.1002/ana.21123
- The paper
- Manto, M., Laute, M., Aguera, M., Rogemond, V., Pandolfo, M., & Honnorat, J. (2007). Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases. Annals of Neurology. https://doi.org/10.1002/ana.21123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.